Form 4: Quest Diagnostics SVP & General Counsel Reports Stock Transactions

Michael E. Prevoznik, SVP & General Counsel of Quest Diagnostics, reports the disposition and acquisition of company stock, including transactions to cover tax obligations and sales under a Rule 10b5-1 plan.

Summary

• Michael E. Prevoznik, a Senior Vice President and General Counsel at Quest Diagnostics, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
• On February 26, 2025, 286 shares were disposed of to cover tax withholding obligations related to vesting restricted stock units at a price of $171.75.
• On February 27, 2025, 528 shares were sold at $172.61 per share under a pre-arranged Rule 10b5-1 sales plan.
• Prevoznik also indirectly owns 5,641 shares through the company's 401(k) and Supplemental Deferred Compensation Plan.
• Following these transactions, Prevoznik directly owns 39,031 shares and indirectly owns 5,641 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders, providing transparency into their trading activities and holdings in their own company's stock. These filings are closely watched by investors seeking insights into management's perspective on the company's prospects.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the trading activity of a key executive.
• The transactions have no direct impact on employees, customers, suppliers, or creditors.

Key Dates